NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity

British Journal of Cancer

Volumn 106, Issue 8, 2012, Pages 1446-1452

  Wang, H ^a   Lee, S ^b   Lo Nigro, C ^c   Lattanzio, L ^c   Merlano, M ^c   Monteverde, M ^c   Matin, R ^d   Purdie, K ^d   Mladkova, N ^d   Bergamaschi, D ^d   Harwood, C ^d   Syed, N ^e   Szlosarek, P ^d   Briasoulis, E ^f   McHugh, A ^a   Thompson, A ^g   Evans, A ^a   Leigh, I ^a   Fleming, C ^a   Inman, G J ^g   Hatzimichael, E ^f   Proby, C ^a   Crook, T ^g   more..

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^c S CROCE E CARLE HOSPITAL   (Italy)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e CHARING CROSS HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

epigenetics; melanoma; metastasis; NT5E

Indexed keywords

5' NUCLEOTIDASE; AZACITIDINE; MESSENGER RNA; TUMOR MARKER;

ARTICLE; BRAIN METASTASIS; CANCER CELL CULTURE; CANCER LOCALIZATION; CONTROLLED STUDY; CPG ISLAND; ENZYME ACTIVATION; ENZYME REGULATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MELANOCYTE; MELANOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; PYROSEQUENCING; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VISCERAL METASTASIS;

5'-NUCLEOTIDASE; BRAIN NEOPLASMS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; GPI-LINKED PROTEINS; HUMANS; MELANOMA; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84862786328     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.95     Document Type: Article

References (11)

1. Andrade CMB, Lopez PLC, Noronha BT, Wink MR, Borojevic R, Margis R, Lenz G, Battastini AMO, Guma FCR (2011) Ecto-5′-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line. Cell Tissue Res 344: 279-286
2. Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z (2011) Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol 187: 676-683
3. Kim G, Kim D-J, Lee S-H, Yeom Y-I, Kang D (2006) Gene expression profile during Mezerein-induced reversible differentiation of human melanoma cells. Kor J Gerontol 16: 201-210
4. Lee S, Syed N, Taylor J, Smith P, Griffin B, Baens M, Bai M, Bourantas K, Stebbing J, Naresh K, Nelson M, Tuthill M, Bower M, Hatzimichael E, Crook T (2010) DUSP16 is an epigenetically-regulated determinant of JNK signalling in Burkitt lymphoma. Br J Cancer 103: 265-274
5. Lopez J, Percharde M, Coley HM, Webb A, Crook T (2009) The context and potential of epigenetics in oncology. Br J Cancer 100: 571-577
6. Sadej R, Spychala J, Skladanowski AC (2006a) Ecto-5′-nucleotidase (eN, CD73) is co-expressed with metastasis promoting antigens in human melanoma cells. Nucleosides Nucleotides Nucleic Acids 25: 1119-1123 (Pubitemid 44651858)
7. Sadej R, Spychala J, Skladanowski AC (2006b) Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res 16: 213-222 (Pubitemid 44085095)
8. Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, Smyth MJ (2011) CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res 71: 2892-2900
9. Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel TJ, Zhang B (2011) CD73 has distinct roles in non hematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest 121: 2371-2382
10. Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T (2006) Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-20-deoxycytidine treatment and oligonucleotide micro-array. Cancer Sci 97: 64-71 (Pubitemid 43257029)
11. Yegutkin GG, Marttila-Ichihara F, Karikoski M, Niemelä J, Laurila JP, Elima K, Jalkanen S, Salmi M (2011) Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. Eur J Immunol 41: 1231-1241